https://www.selleckchem.com/pr....oducts/bos172722.htm
Our results warrant further evaluation in a phase II study. The combination of tipifarnib and bortezomib was tolerated well and appeared to have clinical activity in patients with high-risk MDS and AML with low counts of marrow blasts. Our results warrant further evaluation in a phase II study.We examine climate-related activities through an evolutionary psychology lens, zooming in on factors that motivate or discourage people to behave sustainably to mitigate climate change. Complementing current knowledge, we discuss five core ances
Like
Comment
Share
